Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Citiclark Injection

Prescription Icon
Prescription Required

Marketer

Louis and Clark Pharmaceutical

Salt Composition

Citicoline (250mg/ml)

Overview Citiclark Injection

NeuroClark injection treats stroke, head trauma, Alzheimer's disease, and Parkinson's-related dementia by safeguarding and repairing brain cells, thus enhancing cognitive function. Administered intravenously by a healthcare provider (not for self-injection), it's indicated when oral medication isn't feasible. Follow your doctor's prescribed dosage and regimen; if a dose is missed, take it immediately upon recall. Potential side effects include hypotension, gastrointestinal upset (pain, diarrhea), arrhythmia, skin rash, sleep disturbances, and worsening numbness in affected limbs. Injection site reactions (pain, redness, swelling) may also occur, but are generally transient. Report persistent or bothersome side effects to your physician. Prior to treatment, disclose any kidney issues, history of seizures, or current medications. Dosage is tailored to age and condition. Pregnant, breastfeeding, or planning pregnancy necessitates informing your doctor before commencing treatment.

Uses of Citiclark Injection

Managing stroke, head trauma, Alzheimer's disease, and Parkinson's-related dementia.

Major Benefits of Citiclark Injection:

Administering this medication will be handled by your physician or their associate; self-medication is strictly prohibited.

Common Side effects of Citiclark Injection:

  • Injection site reactions (pain, swelling, redness)
  • Decreased blood pressure
  • Arrhythmia (irregular heartbeats)
  • Stomach pain
  • Diarrhea
  • Insomnia (difficulty in sleeping)
  • Rash
  • Peripheral neuropathy (tingling and numbness of feet and hand)

How to use Citiclark Injection:

This medication will be administered by your healthcare provider. Self-medication is not permitted.

How Citiclark Injection works:

Citiclark Injection safeguards nerve tissue, promoting nerve cell health and survival. This is achieved through the generation of key neurochemicals, such as phosphatidylcholine and acetylcholine, which also mitigate the accumulation of free fatty acids at injury sites.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Citiclark Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the use of Citiclark Injection in pregnant individuals is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Citiclark Injection's compatibility with breastfeeding is absent. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

Citiclark Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

The use of Citiclark Injection requires careful consideration in individuals with impaired kidney function. Dosage modification for Citiclark Injection might be necessary. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Citiclark Injection to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Citiclark Injection :

NA

Facts to Know About Citiclark Injection

LabelValue
Chemical Type Pyrimidine Nucleoside Diphosphate
Developing Habits No.
Type of Therapy Neuroscience of the Central Nervous System
Behavioral Class Cognitive enhancer

FAQs on Citiclark Injection

Citiclark Injection delivers choline, an essential nutrient naturally occurring in the body. It safeguards brain nerve cells from damage and promotes their repair, thereby enhancing learning, memory, and cognitive function in individuals with Alzheimer's disease.
While research on alcohol's interaction with Citiclark Injection is lacking, given its use in treating serious neurological conditions like stroke, Alzheimer's, Parkinson's disease, head injuries, and age-related memory loss, alcohol consumption is best avoided.
Citiclark Injection is unsuitable for students. Studies confirm its efficacy only for age-related memory loss, memory impairment following stroke, and Alzheimer's disease. Its use in children is unsupported by data.
For stroke caused by blood clots, oral Citiclark Injection may aid full recovery within three months. Intravenous Citiclark Injection, administered within 12 hours of stroke onset or daily for seven days post-stroke, may accelerate recovery.
Citiclark Injection
146
MRP 169
13% off